Lymphoma
Several important lymphoma studies presented at ASCO 2026 provided new data across newly diagnosed and relapsed/refractory disease settings. The studies spanned aggressive B-cell lymphomas and classic Hodgkin lymphoma, evaluating novel antibody-based combinations, epigenetic targeting strategies and chemotherapy-sparing approaches. Dr Tycel Phillips provides his expert insights into the six most important studies of the meeting.
2025 has brought exciting developments in haematology, with groundbreaking research and real-world progress showcased at EHA, ASH, EBMT and many more leading conferences around the world. We asked our key faculty to share what they believe has been most impactful so far this year – here’s what they told us.
The 67th ASH Annual Meeting and Exposition brought over 30,000+ attendees, 5,000+ novel abstracts and 275+ exhibitors corporate supporters, academic leaders and patient-advocacy groups. The meeting highlighted innovations ranging from novel agents to real-world evidence and patient-centred care. In this article, hear from the experts on the key breakthroughs and clinical insights set to shape the future of haematology practice.
Discover the practice-changing data shaping the future of myeloma, chronic lymphocytic leukemia and small lymphocytic lymphoma. Our ASH25 coverage highlights the pivotal Majestec-3 results, emerging CAR T-cell innovations, and the landmark BRUIN CLL-313 trial poised to redefine first-line therapy. With expert commentary from Prof. Meletios-Athanasios Dimopoulos, this in-depth analysis uncovers what these breakthroughs mean for clinical practice.
Discover how ASH25 is reshaping frontline lymphoma care, particularly for older and frail patients. From chemolight combinations to the growing role of bispecific antibodies, Dr Tycel Phillips highlights the five key abstracts poised to influence clinical decision-making.
CAR-T cell therapy is rapidly altering the standard of care for lymphoma, offering durable responses—even in high-risk disease—and shifting long-held treatment algorithms. In this exclusive interview, Dr Alexey Danilov explains how CAR-T is advancing into earlier lines, what drives decisions between CAR-T and bispecific antibodies, and why access remains a major barrier.
Dr Alexey Danilov is an internationally recognized expert with renowned expertise in lymphoma and CLL. His career bridges cutting-edge laboratory research with early-phase clinical trials, driving forward innovative therapies that are reshaping outcomes for patients with blood cancers. In this interview, he reflects on what first drew him to haematology, the guiding philosophy that has sustained his career, and the legacy he hopes to leave behind.
Dr Ferran Nadeu, Post-doctoral Researcher at Hospital Clínic de Barcelona, reflects on the mentors who shaped his career, the thrill of discovery, and the importance of collaboration. He discusses milestones in B-cell cancer research and anticipates how cutting-edge sequencing technologies will transform cancer detection, monitoring, and trial design in the coming decade.
The European Hematology Association (EHA) has released its official EHA Perspectives in Hematology reports from the 2025 Annual Congress in Milan, now available in two separate editions covering malignant and non-malignant hematology. Following strong interest in the 2024 pilot report, this expanded format offers deeper insights into scientific and clinical advances across the field.
As touchHAEMATOLOGY approaches 20 years of providing education for busy haematologists, we are looking to the future—and it certainly looks bright!
Diffuse large B cell lymphoma is now understood to consist of multiple molecular subtypes, each with distinct biology and treatment responses. Dr Dan Hodson emphasises the need for standardised genomic profiling in clinical trials to guide subtype-specific therapies and bridge the current disconnect between research findings and clinical application.
Dr Marlies Vanden Bempt, touchHAEMATOLOGY Future Leader 2025, reflects on her journey in haematology, the impact of mentorship, and her hopes for the future of the field. Now launching her own lab, she shares how calm leadership, resilience in research and openness to AI are shaping her vision for the next decade.
Physician burnout is at a critical point. In this episode, Nicky speaks with Dr Alfred Atanda about why so many physicians are burning out and what can be done to change the trend. From personal experience to system-wide solutions, Dr Atanda shares valuable insights on improving physician well-being and building a more effective healthcare culture.
What if your medical degree could launch more than a clinical career? In this candid and compelling read, Dr Jon Edelson shares his lessons for early-career clinicians ready to think beyond the bedside and explore the business of medicine.
CAR T-cell therapy is transforming blood cancer care, yet most eligible patients never receive it. Dr Miguel-Angel Perales outlines how the CAR T Vision Coalition plans to close this gap.
Learning points:
- Understand why timely referral for CAR T is critical
- Learn how real-world data support broader patient eligibility
- Explore solutions to expand delivery beyond academic centres
- Discover strategies to promote equitable access across regions
Dr Côme Bommier reflects on the influences that shaped his career, the evolving landscape of lymphoma treatment and the central role of patients in clinical decision-making. With a clear vision for more personalised and lasting care, he offers thoughtful insight into the challenges and responsibilities of modern haematology.
In this episode, we explore the future of continuing medical education (CME) with the team behind touchIME. Hannah Fisher and Matthew Goodwin share insights into global and US trends, the importance of patient inclusivity and how educational outcomes are evolving to better measure the direct impact of learning on clinical practice and patient care.
Dr Zachary Frosch, Fox Chase Cancer Center, shares how patient priorities guide his clinical decisions and how his research stems from real-world challenges. He also reflects on key lessons from mentorship and the ongoing dialogue between the clinic and the research lab that shapes his work.
Log into your Touch Account
Keep track of your clinical interests and newsletter subscriptions.
Sign up with an Email
Or use a .
Register now for FREE access
Already registered? Login below.
